- Home
- PINC vs HRMY Comparison
PINC vs HRMY Comparison
Compare PINC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINC
- HRMY
- Stock Information
- Founded
- PINC 2013
- HRMY 2017
- Country
- PINC United States
- HRMY United States
- Employees
- PINC N/A
- HRMY N/A
- Industry
- PINC Other Consumer Services
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- PINC Consumer Discretionary
- HRMY Health Care
- Exchange
- PINC Nasdaq
- HRMY Nasdaq
- Market Cap
- PINC 1.9B
- HRMY 1.9B
- IPO Year
- PINC 2013
- HRMY 2020
- Fundamental
- Price
- PINC $21.33
- HRMY $34.77
- Analyst Decision
- PINC Hold
- HRMY Buy
- Analyst Count
- PINC 7
- HRMY 10
- Target Price
- PINC $21.42
- HRMY $49.80
- AVG Volume (30 Days)
- PINC 1.1M
- HRMY 564.2K
- Earning Date
- PINC 02-03-2025
- HRMY 02-20-2025
- Dividend Yield
- PINC 3.96%
- HRMY N/A
- EPS Growth
- PINC N/A
- HRMY N/A
- EPS
- PINC 1.32
- HRMY 2.11
- Revenue
- PINC $1,325,477,000.00
- HRMY $681,879,000.00
- Revenue This Year
- PINC N/A
- HRMY $24.83
- Revenue Next Year
- PINC $1.78
- HRMY $18.66
- P/E Ratio
- PINC $15.78
- HRMY $16.34
- Revenue Growth
- PINC 2.65
- HRMY 25.83
- 52 Week Low
- PINC $17.96
- HRMY $28.14
- 52 Week High
- PINC $23.56
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- PINC 41.40
- HRMY 53.86
- Support Level
- PINC $20.96
- HRMY $33.36
- Resistance Level
- PINC $21.98
- HRMY $34.96
- Average True Range (ATR)
- PINC 0.49
- HRMY 1.18
- MACD
- PINC -0.06
- HRMY 0.15
- Stochastic Oscillator
- PINC 19.56
- HRMY 75.61
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.